C2-streptavidin mediates the delivery of biotin-conjugated tumor suppressor protein P53 into tumor cells

Bioconjugate Chemistry

Volumn 24, Issue 4, 2013, Pages 595-603

  Fahrer, Jörg ^a,b   Schweitzer, Brigitte ^a,c   Fiedler, Katja ^a   Langer, Torben ^a   Gierschik, Peter ^a   Barth, Holger ^a  

^a UNIVERSITY HOSPITAL ULM   (Germany)

^b UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^c KARLSRUHE INSTITUTE OF TECHNOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CULTURE; CELLS; CONFOCAL MICROSCOPY; DISEASES; LANTHANUM COMPOUNDS; MAMMALS; MOLECULAR BIOLOGY; MOLECULES; RECOMBINANT PROTEINS; SURFACE PLASMON RESONANCE; TUMORS;

CELLULAR UPTAKE; CLOSTRIDIUM BOTULINUM; CYTOSOLS; FUSION PROTEINS; LABELLED MOLECULES; LOW MOLECULAR WEIGHT; MAMMALIAN CELLS; STREPTAVIDIN; TUMOR SUPPRESSOR PROTEINS; TUMOUR CELLS;

COENZYMES;

BIOTIN; BOTULINUM TOXIN; CLOSTRIDIUM BOTULINUM C2 TOXIN; RECOMBINANT PROTEIN; RECOMBINANT PROTEIN P53; STREPTAVIDIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; BINDING COMPETITION; BIOLOGICAL MONITORING; CELL FRACTIONATION; CLOSTRIDIUM BOTULINUM; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DNA BINDING; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; ENDOCYTOSIS; FEMALE; HELA CELL; HUMAN; HUMAN CELL; INSECT CELL; NONHUMAN; PROMYELOCYTIC LEUKEMIA; PROTEIN DEGRADATION; PROTEIN EXPRESSION; SURFACE PLASMON RESONANCE; VERO CELL;

CERCOPITHECUS AETHIOPS; CLOSTRIDIUM BOTULINUM; HEXAPODA; MAMMALIA;

EID: 84876474969     PISSN: 10431802     EISSN: 15204812     Source Type: Journal    
DOI: 10.1021/bc300563c     Document Type: Article

References (45)

1. Barth, H. and Stiles, B. G. (2008) Binary actin-ADP-ribosylating toxins and their use as molecular Trojan horses for drug delivery into eukaryotic cells Curr. Med. Chem. 15, 459-69
2. Barth, H., Blocker, D., Behlke, J., Bergsma-Schutter, W., Brisson, A., Benz, R., and Aktories, K. (2000) Cellular uptake of Clostridium botulinum C2 toxin requires oligomerization and acidification J. Biol. Chem. 275, 18704-11
3. Eckhardt, M., Barth, H., Blocker, D., and Aktories, K. (2000) Binding of Clostridium botulinum C2 toxin to asparagine-linked complex and hybrid carbohydrates J. Biol. Chem. 275, 2328-34
4. Nagahama, M., Hagiyama, T., Kojima, T., Aoyanagi, K., Takahashi, C., Oda, M., Sakaguchi, Y., Oguma, K., and Sakurai, J. (2009) Binding and internalization of Clostridium botulinum C2 toxin Infect. Immun. 77, 5139-48
5. Pust, S., Barth, H., and Sandvig, K. (2010) Clostridium botulinum C2 toxin is internalized by clathrin-and Rho-dependent mechanisms Cell Microbiol. 12, 1809-20
6. Haug, G., Leemhuis, J., Tiemann, D., Meyer, D. K., Aktories, K., and Barth, H. (2003) The host cell chaperone Hsp90 is essential for translocation of the binary Clostridium botulinum C2 toxin into the cytosol J. Biol. Chem. 278, 32266-74
7. Kaiser, E., Pust, S., Kroll, C., and Barth, H. (2009) Cyclophilin A facilitates translocation of the Clostridium botulinum C2 toxin across membranes of acidified endosomes into the cytosol of mammalian cells Cell Microbiol. 11, 780-95
8. Kaiser, E., Bohm, N., Ernst, K., Langer, S., Schwan, C., Aktories, K., Popoff, M., Fischer, G., and Barth, H. (2012) FK506-binding protein 51 interacts with Clostridium botulinum C2 toxin and FK506 inhibits membrane translocation of the toxin in mammalian cells Cell Microbiol. 14, 1193-205
9. Wegner, A. and Aktories, K. (1988) ADP-ribosylated actin caps the barbed ends of actin filaments J. Biol. Chem. 263, 13739-42
10. Heine, K., Pust, S., Enzenmuller, S., and Barth, H. (2008) ADP-ribosylation of actin by the Clostridium botulinum C2 toxin in mammalian cells results in delayed caspase-dependent apoptotic cell death Infect. Immun. 76, 4600-8
11. Barth, H., Hofmann, F., Olenik, C., Just, I., and Aktories, K. (1998) The N-terminal part of the enzyme component (C2I) of the binary Clostridium botulinum C2 toxin interacts with the binding component C2II and functions as a carrier system for a Rho ADP-ribosylating C3-like fusion toxin Infect. Immun. 66, 1364-9
12. Fahrer, J., Plunien, R., Binder, U., Langer, T., Seliger, H., and Barth, H. (2010) Genetically engineered clostridial C2 toxin as a novel delivery system for living mammalian cells Bioconjugate Chem. 21, 130-9
13. Laitinen, O. H., Hytonen, V. P., Nordlund, H. R., and Kulomaa, M. S. (2006) Genetically engineered avidins and streptavidins Cell. Mol. Life Sci. 63, 2992-3017
14. Lesch, H. P., Kaikkonen, M. U., Pikkarainen, J. T., and Yla-Herttuala, S. (2010) Avidin-biotin technology in targeted therapy Expert Opin. Drug Delivery 7, 551-64
15. Fahrer, J., Rieger, J., van Zandbergen, G., and Barth, H. (2010) The C2-streptavidin delivery system promotes the uptake of biotinylated molecules in macrophages and T-leukemia cells Biol. Chem. 391, 1315-25
16. Romer, L., Klein, C., Dehner, A., Kessler, H., and Buchner, J. (2006) p53 -a natural cancer killer: structural insights and therapeutic concepts Angew. Chem., Int. Ed. Engl. 45, 6440-60
17. Horn, H. F. and Vousden, K. H. (2007) Coping with stress: multiple ways to activate p53 Oncogene 26, 1306-16
18. Toledo, F. and Wahl, G. M. (2006) Regulating the p53 pathway: in vitro hypotheses, in vivo veritas Nat. Rev. Cancer 6, 909-23
19. Olivier, M., Hollstein, M., and Hainaut, P. (2010) TP53 mutations in human cancers: origins, consequences, and clinical use Cold Spring Harbor Perspect. Biol. 2, a001008
20. Zeng, X., Sun, Y. X., Qu, W., Zhang, X. Z., and Zhuo, R. X. (2010) Biotinylated transferrin/avidin/biotinylated disulfide containing PEI bioconjugates mediated p53 gene delivery system for tumor targeted transfection Biomaterials 31, 4771-80
21. Zhao, D., Liu, C., Zhuo, R. X., and Cheng, S. X. (2012) Alginate/CaCO3 Hybrid Nanoparticles for Efficient Co-delivery of Anti-tumor Gene and Drug Mol. Pharmaceutics 9, 2887
22. Takenobu, T., Tomizawa, K., Matsushita, M., Li, S. T., Moriwaki, A., Lu, Y. F., and Matsui, H. (2002) Development of p53 protein transduction therapy using membrane-permeable peptides and the application to oral cancer cells Mol. Cancer Ther. 1, 1043-9
23. Lafevre-Bernt, M., Wu, S., and Lin, X. (2008) Recombinant, refolded tetrameric p53 and gonadotropin-releasing hormone-p53 slow proliferation and induce apoptosis in p53-deficient cancer cells Mol. Cancer Ther. 7, 1420-9
24. Fahrer, J., Kranaster, R., Altmeyer, M., Marx, A., and Burkle, A. (2007) Quantitative analysis of the binding affinity of poly(ADP-ribose) to specific binding proteins as a function of chain length Nucleic Acids Res. 35, e143
25. Jiang, X., Ahmed, M., Deng, Z., and Narain, R. (2009) Biotinylated glyco-functionalized quantum dots: synthesis, characterization, and cytotoxicity studies Bioconjugate Chem. 20, 994-1001
26. Sun, X. Z., Nguyen, J., and Momand, J. (2003) Purification of recombinant p53 from Sf9 insect cells Methods Mol. Biol. 234, 17-28
27. Sorensen, V., Zhen, Y., Zakrzewska, M., Haugsten, E. M., Walchli, S., Nilsen, T., Olsnes, S., and Wiedlocha, A. (2008) Phosphorylation of fibroblast growth factor (FGF) receptor 1 at Ser777 by p38 mitogen-activated protein kinase regulates translocation of exogenous FGF1 to the cytosol and nucleus Mol. Cell. Biol. 28, 4129-41
28. Bucci, C., Parton, R. G., Mather, I. H., Stunnenberg, H., Simons, K., Hoflack, B., and Zerial, M. (1992) The small GTPase rab5 functions as a regulatory factor in the early endocytic pathway Cell 70, 715-28
29. Scheffner, M., Huibregtse, J. M., Vierstra, R. D., and Howley, P. M. (1993) The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53 Cell 75, 495-505
30. Wittrup, A. and Belting, M. (2009) Characterizing peptide-mediated DNA internalization in human cancer cells Methods Mol. Biol. 480, 101-12
31. Kane, S. A., Fleener, C. A., Zhang, Y. S., Davis, L. J., Musselman, A. L., and Huang, P. S. (2000) Development of a binding assay for p53/HDM2 by using homogeneous time-resolved fluorescence Anal. Biochem. 278, 29-38
32. Sano, T., Vajda, S., Smith, C. L., and Cantor, C. R. (1997) Engineering subunit association of multisubunit proteins: a dimeric streptavidin Proc. Natl. Acad. Sci. U. S. A. 94, 6153-8
33. Wolf, B. (2005) Biotinidase: its role in biotinidase deficiency and biotin metabolism J. Nutr. Biochem. 16, 441-5
34. Chu, T. C., Twu, K. Y., Ellington, A. D., and Levy, M. (2006) Aptamer mediated siRNA delivery Nucleic Acids Res. 34, e73
35. Giannakakou, P., Sackett, D. L., Ward, Y., Webster, K. R., Blagosklonny, M. V., and Fojo, T. (2000) p53 is associated with cellular microtubules and is transported to the nucleus by dynein Nat. Cell Biol. 2, 709-17
36. Liang, S. H. and Clarke, M. F. (1999) A bipartite nuclear localization signal is required for p53 nuclear import regulated by a carboxyl-terminal domain J. Biol. Chem. 274, 32699-703
37. Schleberger, C., Hochmann, H., Barth, H., Aktories, K., and Schulz, G. E. (2006) Structure and action of the binary C2 toxin from Clostridium botulinum J. Mol. Biol. 364, 705-15
38. Blocker, D., Barth, H., Maier, E., Benz, R., Barbieri, J. T., and Aktories, K. (2000) The C terminus of component C2II of Clostridium botulinum C2 toxin is essential for receptor binding Infect. Immun. 68, 4566-73
39. Mechaly, A., McCluskey, A. J., and Collier, R. J. (2012) Changing the receptor specificity of anthrax toxin. mBIO 3, e00088-12.
40. Weitman, S. D., Lark, R. H., Coney, L. R., Fort, D. W., Frasca, V., Zurawski, V. R., Jr., and Kamen, B. A. (1992) Distribution of the folate receptor GP38 in normal and malignant cell lines and tissues Cancer Res. 52, 3396-401
41. Yotsumoto, F., Sanui, A., Fukami, T., Shirota, K., Horiuchi, S., Tsujioka, H., Yoshizato, T., Kuroki, M., and Miyamoto, S. (2009) Efficacy of ligand-based targeting for the EGF system in cancer Anticancer Res. 29, 4879-85
42. Huo, M., Zou, A., Yao, C., Zhang, Y., Zhou, J., Wang, J., Zhu, Q., Li, J., and Zhang, Q. (2012) Somatostatin receptor-mediated tumor-targeting drug delivery using octreotide-PEG-deoxycholic acid conjugate-modified N-deoxycholic acid-O, N-hydroxyethylation chitosan micelles Biomaterials 33, 6393-407
43. Goldenberg, D. M., Sharkey, R. M., Paganelli, G., Barbet, J., and Chatal, J. F. (2006) Antibody pretargeting advances cancer radioimmunodetection and radioimmunotherapy J. Clin. Oncol. 24, 823-34
44. Meyer, D. L., Schultz, J., Lin, Y., Henry, A., Sanderson, J., Jackson, J. M., Goshorn, S., Rees, A. R., and Graves, S. S. (2001) Reduced antibody response to streptavidin through site-directed mutagenesis Protein Sci. 10, 491-503
45. Wu, D. and Pardridge, W. M. (1996) Central nervous system pharmacologic effect in conscious rats after intravenous injection of a biotinylated vasoactive intestinal peptide analog coupled to a blood-brain barrier drug delivery system J. Pharmacol. Exp. Ther. 279, 77-83